Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic
  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Ascendis Pharma A/S - Ordinary Share (NQ:ASND)

240.50 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 15, 2026 Add to My Watchlist

Price and Volume

Detailed Quote
Volume 0
Open 240.50
Bid (Size) 238.02 (100)
Ask (Size) 384.80 (200)
Prev. Close 240.50
Today's Range 240.50 - 240.50
52wk Range 153.49 - 250.74
Shares Outstanding 57,152,295
Dividend Yield N/A

Performance

YTD
+12.8%
+12.8%
1 Month
-1.6%
-1.6%
3 Month
+7.6%
+7.6%
6 Month
+11.1%
+11.1%
1 Year
+50.0%
+50.0%

More News

Read More

Frequently Asked Questions

Is Ascendis Pharma A/S - Ordinary Share publicly traded?
Yes, Ascendis Pharma A/S - Ordinary Share is publicly traded.
What exchange does Ascendis Pharma A/S - Ordinary Share trade on?
Ascendis Pharma A/S - Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Ascendis Pharma A/S - Ordinary Share?
The ticker symbol for Ascendis Pharma A/S - Ordinary Share is ASND on the Nasdaq Stock Market
What is the current price of Ascendis Pharma A/S - Ordinary Share?
The current price of Ascendis Pharma A/S - Ordinary Share is 240.50
When was Ascendis Pharma A/S - Ordinary Share last traded?
The last trade of Ascendis Pharma A/S - Ordinary Share was at 05/15/26 04:00 PM ET
What is the market capitalization of Ascendis Pharma A/S - Ordinary Share?
The market capitalization of Ascendis Pharma A/S - Ordinary Share is 13.75B
How many shares of Ascendis Pharma A/S - Ordinary Share are outstanding?
Ascendis Pharma A/S - Ordinary Share has 14B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
 
 
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.